Comparison 13.

Mifepristone versus gestrinone

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Observed number of pregnancies (all women)	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	0.75 [0.32, 1.76]
2 Side effects	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
2.1 Nausea	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	1.34 [0.90, 2.00]
2.2 Vomiting	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.06, 15.94]
2.3 Headache	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	0.67 [0.19, 2.35]
2.4 Dizziness	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	1.63 [0.68, 3.89]
2.5 Fatigue	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	2.0 [0.91, 4.41]
2.6 Breast tenderness	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	0.57 [0.17, 1.94]
2.7 Diarrhoea	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	0.25 [0.03, 2.23]
2.8 Bleeding or spotting	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	0.94 [0.70, 1.26]
2.9 Lower abdominal pain	1	996	Risk Ratio (M‐H, Fixed, 95% CI)	0.89 [0.35, 2.29]
3 Menses	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3.1 Early	1	975	Risk Ratio (M‐H, Fixed, 95% CI)	0.37 [0.20, 0.69]
3.2 Delay	1	975	Risk Ratio (M‐H, Fixed, 95% CI)	1.37 [1.03, 1.82]